RIGL · Rigel Pharmaceuticals Inc. Common Stock
View on chartInsiders & Stakes
| RODRIGUEZ RAUL R CEO, President | ▼ Sell | Tax Withholding | 273,362 Shares held | 9/1/2026 | View profile |
| Kotzin Brian L. | ▲ Buy | Grant | 100,000 Shares held | 5/25/2024 | View profile |
| Schorno Dean L EVP &Chief Financial Officer | ▲ Buy | Option Exercise | 82,962 Shares held | 9/2/2026 | View profile |
| Gary A. Lyons Director | ▲ Buy | Grant | 75,000 Shares held | 5/26/2023 | View profile |
| Dummer Wolfgang EVP & CMO | ▼ Sell | Open Market | 72,459 Shares held | 2/2/2023 | View profile |
| Santos David A EVP, Chief Commercial Officer | ▼ Sell | Tax Withholding | 61,622 Shares held | 9/1/2026 | View profile |
| VANCE DOLLY EVP Corp. Affairs, G.C., Sect. | ▲ Buy | Grant | 60,260 Shares held | 1/24/2022 | View profile |
| Furey Raymond J. EVP, GC, CCO & Corp Sec | ▼ Sell | Tax Withholding | 50,559 Shares held | 9/1/2026 | View profile |
| HANNAH ALISON L. Director | ▲ Buy | Grant | 35,025 Shares held | 7/8/2026 | View profile |
| Rojkjaer Lisa EVP, Chief Medical Officer | ▼ Sell | Tax Withholding | 34,003 Shares held | 6/1/2026 | View profile |
| MOOS WALTER H | ▲ Buy | Grant | 18,472 Shares held | 5/15/2026 | View profile |
| Wasman Jane Director | ▲ Buy | Grant | 18,250 Shares held | 5/15/2026 | View profile |
| LAPOINTE ANTHONY GREGG | ▲ Buy | Grant | 18,250 Shares held | 5/15/2026 | View profile |
| Ali-Jackson Kamil Chief Legal Officer | ▼ Sell | Open Market | 10,125 Shares held | 6/22/2026 | View profile |
| Frohlich Mark W | ▲ Buy | Grant | 7,000 Shares held | 5/15/2026 | View profile |
| MILLER MICHAEL PATRICK Director | ▲ Buy | Grant | 5,937 Shares held | 5/15/2026 | View profile |
Transaction History
| Schorno Dean L | ▲ Buy | Option Exercise | 694 | $9K | 9/2/2026 |
| Schorno Dean L | ▲ Buy | Option Exercise | 620 | $12K | 9/2/2026 |
| Schorno Dean L | ▲ Buy | Option Exercise | 2,000 | $48K | 9/2/2026 |
| Schorno Dean L | ▲ Buy | Option Exercise | 1,286 | $31K | 9/2/2026 |
| Schorno Dean L | ▼ Sell | Tax Withholding | 928 | $44K | 9/1/2026 |
| Santos David A | ▼ Sell | Tax Withholding | 874 | $42K | 9/1/2026 |
| RODRIGUEZ RAUL R | ▼ Sell | Tax Withholding | 2,424 | $115K | 9/1/2026 |
| Furey Raymond J. | ▼ Sell | Tax Withholding | 877 | $42K | 9/1/2026 |
| HANNAH ALISON L. | ▲ Buy | Grant | 24,400 | $0 | 7/8/2026 |
| Ali-Jackson Kamil | ▼ Sell | Open Market | 2,500 | $88K | 6/22/2026 |
| Schorno Dean L | ▲ Buy | Option Exercise | 1,200 | $22K | 6/1/2026 |
| Schorno Dean L | ▲ Buy | Option Exercise | 2,181 | $28K | 6/1/2026 |
| Schorno Dean L | ▼ Sell | Tax Withholding | 928 | $28K | 6/1/2026 |
| Santos David A | ▼ Sell | Tax Withholding | 874 | $26K | 6/1/2026 |
| Rojkjaer Lisa | ▼ Sell | Tax Withholding | 850 | $25K | 6/1/2026 |
| RODRIGUEZ RAUL R | ▼ Sell | Tax Withholding | 2,424 | $72K | 6/1/2026 |
| Furey Raymond J. | ▼ Sell | Tax Withholding | 877 | $26K | 6/1/2026 |
| Ali-Jackson Kamil | ▼ Sell | Open Market | 2,500 | $73K | 5/26/2026 |
| Ali-Jackson Kamil | ▲ Buy | Grant | 5,750 | $0 | 5/15/2026 |
| LAPOINTE ANTHONY GREGG | ▲ Buy | Grant | 5,750 | $0 | 5/15/2026 |
| HANNAH ALISON L. | ▲ Buy | Grant | 5,750 | $0 | 5/15/2026 |
| Frohlich Mark W | ▲ Buy | Grant | 5,750 | $0 | 5/15/2026 |
| MILLER MICHAEL PATRICK | ▲ Buy | Grant | 5,750 | $0 | 5/15/2026 |
| MOOS WALTER H | ▲ Buy | Grant | 5,750 | $0 | 5/15/2026 |
| Wasman Jane | ▲ Buy | Grant | 5,750 | $0 | 5/15/2026 |
| MOOS WALTER H | ▲ Buy | Option Exercise | 4,000 | $96K | 2/20/2026 |
| MOOS WALTER H | ▼ Sell | Open Market | 4,000 | $145K | 2/20/2026 |
| Furey Raymond J. | ▲ Buy | Grant | 19,497 | $0 | 2/17/2026 |
| RODRIGUEZ RAUL R | ▲ Buy | Grant | 53,915 | $0 | 2/17/2026 |
| Rojkjaer Lisa | ▲ Buy | Grant | 18,894 | $0 | 2/17/2026 |
| Santos David A | ▲ Buy | Grant | 19,430 | $0 | 2/17/2026 |
| Schorno Dean L | ▲ Buy | Grant | 20,636 | $0 | 2/17/2026 |
| Schorno Dean L | ▼ Sell | Tax Withholding | 3,546 | $123K | 2/10/2026 |
| Furey Raymond J. | ▼ Sell | Tax Withholding | 3,546 | $123K | 2/10/2026 |
| Santos David A | ▼ Sell | Tax Withholding | 3,546 | $123K | 2/10/2026 |
| RODRIGUEZ RAUL R | ▼ Sell | Tax Withholding | 7,607 | $263K | 2/10/2026 |
| Rojkjaer Lisa | ▼ Sell | Tax Withholding | 3,758 | $130K | 2/10/2026 |
| Santos David A | ▼ Sell | Tax Withholding | 5,718 | $206K | 2/2/2026 |
| Schorno Dean L | ▼ Sell | Tax Withholding | 5,488 | $198K | 2/2/2026 |
| Furey Raymond J. | ▼ Sell | Tax Withholding | 3,968 | $143K | 2/2/2026 |
| RODRIGUEZ RAUL R | ▼ Sell | Tax Withholding | 14,110 | $508K | 2/2/2026 |
| RODRIGUEZ RAUL R | ▲ Buy | Option Exercise | 40,000 | $1.1M | 1/26/2026 |
| RODRIGUEZ RAUL R | ▼ Sell | Tax Withholding | 35,211 | $1.3M | 1/26/2026 |
| RODRIGUEZ RAUL R | ▲ Buy | Option Exercise | 40,000 | $1.1M | 1/26/2026 |
| RODRIGUEZ RAUL R | ▼ Sell | Tax Withholding | 35,424 | $1.3M | 1/26/2026 |
| Schorno Dean L | ▲ Buy | Option Exercise | 1,987 | $40K | 12/22/2025 |
| Schorno Dean L | ▲ Buy | Option Exercise | 2,846 | $69K | 12/22/2025 |
| Schorno Dean L | ▲ Buy | Option Exercise | 1,667 | $31K | 12/22/2025 |
| MOOS WALTER H | ▲ Buy | Grant | 2,500 | $0 | 5/23/2025 |
| LAPOINTE ANTHONY GREGG | ▲ Buy | Grant | 2,500 | $0 | 5/23/2025 |
| Frohlich Mark W | ▲ Buy | Grant | 1,250 | $0 | 5/23/2025 |
| Ali-Jackson Kamil | ▲ Buy | Grant | 2,500 | $0 | 5/23/2025 |
| Wasman Jane | ▲ Buy | Grant | 2,500 | $0 | 5/23/2025 |
| HANNAH ALISON L. | ▲ Buy | Grant | 2,500 | $0 | 5/23/2025 |
| Schorno Dean L | ▼ Sell | Open Market | 1,734 | $38K | 2/5/2025 |
| Santos David A | ▼ Sell | Open Market | 1,796 | $39K | 2/5/2025 |
| RODRIGUEZ RAUL R | ▼ Sell | Open Market | 4,400 | $96K | 2/5/2025 |
| Furey Raymond J. | ▼ Sell | Open Market | 1,339 | $29K | 2/5/2025 |
| Schorno Dean L | ▼ Sell | Open Market | 2,036 | $43K | 2/4/2025 |
| Santos David A | ▼ Sell | Open Market | 2,125 | $44K | 2/4/2025 |
| RODRIGUEZ RAUL R | ▼ Sell | Open Market | 4,952 | $104K | 2/4/2025 |
| Furey Raymond J. | ▼ Sell | Open Market | 1,448 | $30K | 2/4/2025 |
| Rojkjaer Lisa | ▲ Buy | Grant | 19,717 | $0 | 1/29/2025 |
| RODRIGUEZ RAUL R | ▲ Buy | Grant | 42,300 | $0 | 1/29/2025 |
| Schorno Dean L | ▲ Buy | Grant | 19,717 | $0 | 1/29/2025 |
| Santos David A | ▲ Buy | Grant | 19,717 | $0 | 1/29/2025 |
| Furey Raymond J. | ▲ Buy | Grant | 19,717 | $0 | 1/29/2025 |
| RODRIGUEZ RAUL R | ▲ Buy | Option Exercise | 45,000 | $963K | 1/24/2025 |
| RODRIGUEZ RAUL R | ▼ Sell | Tax Withholding | 44,078 | $977K | 1/24/2025 |
| RODRIGUEZ RAUL R | ▲ Buy | Option Exercise | 45,000 | $963K | 1/24/2025 |
| RODRIGUEZ RAUL R | ▼ Sell | Tax Withholding | 44,078 | $977K | 1/24/2025 |
| HANNAH ALISON L. | ▲ Buy | Grant | 25,000 | $0 | 5/25/2024 |
| Ali-Jackson Kamil | ▲ Buy | Grant | 25,000 | $0 | 5/25/2024 |
| Wasman Jane | ▲ Buy | Grant | 25,000 | $0 | 5/25/2024 |
| MOOS WALTER H | ▲ Buy | Grant | 25,000 | $0 | 5/25/2024 |
| LAPOINTE ANTHONY GREGG | ▲ Buy | Grant | 25,000 | $0 | 5/25/2024 |
| Kotzin Brian L. | ▲ Buy | Grant | 25,000 | $0 | 5/25/2024 |
| Santos David A | ▼ Sell | Open Market | 8,918 | $10K | 2/5/2024 |
| Schorno Dean L | ▼ Sell | Open Market | 7,027 | $8K | 2/5/2024 |
| RODRIGUEZ RAUL R | ▼ Sell | Open Market | 30,545 | $35K | 2/5/2024 |
| Santos David A | ▼ Sell | Open Market | 5,601 | $6K | 2/2/2024 |
| Schorno Dean L | ▼ Sell | Open Market | 5,601 | $6K | 2/2/2024 |
| RODRIGUEZ RAUL R | ▼ Sell | Open Market | 22,349 | $25K | 2/2/2024 |
| Furey Raymond J. | ▲ Buy | Grant | 209,000 | $0 | 1/23/2024 |
| RODRIGUEZ RAUL R | ▲ Buy | Grant | 400,000 | $0 | 1/23/2024 |
| Santos David A | ▲ Buy | Grant | 209,000 | $0 | 1/23/2024 |
| Schorno Dean L | ▲ Buy | Grant | 209,000 | $0 | 1/23/2024 |
| LAPOINTE ANTHONY GREGG | ▲ Buy | Grant | 25,000 | $0 | 5/26/2023 |
| MOOS WALTER H | ▲ Buy | Grant | 25,000 | $0 | 5/26/2023 |
| Wasman Jane | ▲ Buy | Grant | 25,000 | $0 | 5/26/2023 |
| Gary A. Lyons | ▲ Buy | Grant | 25,000 | $0 | 5/26/2023 |
| Ali-Jackson Kamil | ▲ Buy | Grant | 25,000 | $0 | 5/26/2023 |
| Kotzin Brian L. | ▲ Buy | Grant | 25,000 | $0 | 5/26/2023 |
| HANNAH ALISON L. | ▲ Buy | Grant | 25,000 | $0 | 5/26/2023 |
| RODRIGUEZ RAUL R | ▼ Sell | Open Market | 20,340 | $36K | 2/6/2023 |
| Santos David A | ▼ Sell | Open Market | 5,388 | $9K | 2/2/2023 |
| Schorno Dean L | ▼ Sell | Open Market | 5,389 | $9K | 2/2/2023 |
| Dummer Wolfgang | ▼ Sell | Open Market | 5,389 | $9K | 2/2/2023 |
| RODRIGUEZ RAUL R | ▲ Buy | Grant | 300,000 | $0 | 1/26/2023 |
| Schorno Dean L | ▲ Buy | Grant | 63,000 | $0 | 1/26/2023 |
| Santos David A | ▲ Buy | Grant | 80,000 | $0 | 1/26/2023 |
| RODRIGUEZ RAUL R | ▲ Buy | Open Market | 1,000,000 | $688K | 6/9/2022 |
| MOOS WALTER H | ▲ Buy | Grant | 25,000 | $0 | 5/20/2022 |
| Wasman Jane | ▲ Buy | Grant | 25,000 | $0 | 5/20/2022 |
| LAPOINTE ANTHONY GREGG | ▲ Buy | Grant | 25,000 | $0 | 5/20/2022 |
| Gary A. Lyons | ▲ Buy | Grant | 25,000 | $0 | 5/20/2022 |
| HANNAH ALISON L. | ▲ Buy | Grant | 25,000 | $0 | 5/20/2022 |
| Ali-Jackson Kamil | ▲ Buy | Grant | 18,750 | $0 | 5/20/2022 |
| Kotzin Brian L. | ▲ Buy | Grant | 25,000 | $0 | 5/20/2022 |
| RODRIGUEZ RAUL R | ▲ Buy | Grant | 200,000 | $0 | 1/24/2022 |
| VANCE DOLLY | ▲ Buy | Grant | 50,000 | $0 | 1/24/2022 |
| Santos David A | ▲ Buy | Grant | 50,000 | $0 | 1/24/2022 |
| Schorno Dean L | ▲ Buy | Grant | 50,000 | $0 | 1/24/2022 |
| Dummer Wolfgang | ▲ Buy | Grant | 50,000 | $0 | 1/24/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
RIGL: No Recent Company-Specific News Identified
Recent news coverage for Rigel Pharmaceuticals focuses on a different company, Arvinas, rather than RIGL-specific developments. There are no new announcements or events in the provided data that directly impact RIGL's stock performance. The current technical indicators show the stock trading near its support level, but without specific news catalysts, market attention remains limited to broader sector trends.
RIGL: No Recent Company-Specific News Identified. Recent news coverage for Rigel Pharmaceuticals focuses on a different company, Arvinas, rather than RIGL-specific developments. There are no new announcements or events in the provided data that directly impact RIGL's stock performance. The current technical indicators show the stock trading near its support level, but without specific news catalysts, market attention remains limited to broader sector trends.